PheWAS and GWAS of Telomere Length to Understand Human Disease
PheWAS and GWAS of Telomere Length to Understand Human Disease
批准号:
10264785
负责人:
Scott Joseph Hebbring
金额:
$46.72万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-16 至 2024-07-31
关键词:
African AmericanAgeBenignBiologicalBiological AssayBiological ClocksBiologyBreastCatalytic RNACell AgingCell SurvivalCellsChromosomal StabilityChromosomesClinicCodeComplexDNADNA SequenceDataDiagnosticDiseaseElectronic Health RecordEnvironmental Risk FactorEtiologyFutureGenesGeneticGenetic Predisposition to DiseaseGenomeGenomicsGenotypeGliomaGoalsHealthHealthcare SystemsHumanIndividualInternational Classification of Disease CodesKnowledgeLengthLinkMalignant NeoplasmsMeasuresMedicalMendelian randomizationMethodological StudiesPancreasParticipantPatientsPhenotypePlayPopulationPopulation HeterogeneityProcessPropertyProstateRiskRoleSamplingTelomeraseTestingTimeTranscendVariantbead chipbiobankclinically significantethnic diversityexomeexperimental studyfollow-upfunctional genomicsgenetic variantgenome integritygenome wide association studygenome-widegenomic biomarkergenomic datahuman diseaseillness lengthinnovationinsightlifetime risknovelpersonalized medicinephenomephenotypic dataracial diversitytelomeretraittumortumorigenesiswhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT:
Human diseases are influenced by complex interactions between genetic and environmental factors.
Identifying genomic biomarkers that can transcend these complexities would be of great importance.
Telomeres are repetitive DNA sequences that cap the ends of chromosomes. They are necessary for
maintaining chromosomal stability and play an important role in cell viability. As humans age, telomeres
become shorter with every cellular division thus providing the cell with an internal biological clock for
viability. When telomeres become excessively short, the cell enters replicative senescence.
Dysregulation of telomeres is common in many cancers, and variability in telomere length (TL) is known
to be associated with many diseases. Genome-wide association studies (GWASs) have also identified
approximately 30 candidate variants that influence normal variation in TL, and some of these variants
have been linked to human disease. It is hypothesized that TL, and variants that are associated with
TL, may provide diagnostic and predictive information for many diseases. To test this hypothesis, we
propose the following aims: (1) associate thousands of clinically significant phenotypes with TL by
phenome-wide association studies (PheWAS), (2) conduct the largest single GWAS of TL to identify
novel variants associated with the trait, and (3) identify diseases that are associated with genetic
variants that influence TL by PheWAS. To accomplish these aims, this study will leverage 70,000
ethnically diverse DNA samples from two large healthcare systems. All DNA samples are linked to
genomic data and long-term electronic health records. Through the proposed GWAS and PheWAS
experiments, we expect to gain knowledge concerning the importance of telomere biology in human
health and its diagnostic utility for various diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PheWAS and GWAS of Telomere Length to Understand Human Disease
-
批准号:10458116
-
项目类别:
-
资助金额:$46.59万
-
财政年份:2020
-
负责人:Scott Joseph Hebbring
-
依托单位:
PheWAS and GWAS of Telomere Length to Understand Human Disease
-
批准号:10664860
-
项目类别:
-
资助金额:$44.38万
-
财政年份:2020
-
负责人:Scott Joseph Hebbring
-
依托单位:
PheWAS and GWAS of Telomere Length to Understand Human Disease
-
批准号:9886470
-
项目类别:
-
资助金额:$45.75万
-
财政年份:2020
-
负责人:Scott Joseph Hebbring
-
依托单位:
PheWAS of Loss-of-Function Variants
-
批准号:9333383
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2015
-
负责人:Scott Joseph Hebbring
-
依托单位:
PheWAS of Loss-of-Function Variants
-
批准号:9143153
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2015
-
负责人:Scott Joseph Hebbring
-
依托单位:
Development and Application of Phenome-wide Scan of Heritability (PheSH)
-
批准号:8679493
-
项目类别:
-
资助金额:$14.52万
-
财政年份:2014
-
负责人:Scott Joseph Hebbring
-
依托单位:
Development and Application of Phenome-wide Scan of Heritability (PheSH)
-
批准号:8853944
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2014
-
负责人:Scott Joseph Hebbring
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: